{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:58:42Z","timestamp":1775278722186,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1004582"],"award-info":[{"award-number":["NRF-2019R1A2C1004582"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12272-022-01422-1","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:03:34Z","timestamp":1671617014000},"page":"59-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone"],"prefix":"10.1007","volume":"46","author":[{"given":"Chang\u2011Keun","family":"Cho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Byeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pureum","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-In","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon-Gon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4162-1981","authenticated-orcid":false,"given":"Seok-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ik","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung\u2011Woo","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun Jeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"issue":"2","key":"1422_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5414\/cpp45110","volume":"45","author":"JW Bae","year":"2007","unstructured":"Bae JW, Kim MJ, Park YS, Myung CS, Jang CG, Lee SY (2007) Considerable interindividual variation in the pharmacokinetics of tolperisone HCl. Int J Clin Pharmacol Ther 45(2):110\u2013113. https:\/\/doi.org\/10.5414\/cpp45110","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"11","key":"1422_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1007\/s12272-020-01293-4","volume":"43","author":"JW Bae","year":"2020","unstructured":"Bae JW, Oh KY, Yoon SJ, Shin HB, Jung EH, Cho CK, Lim CW, Kang P, Choi CI, Jang CG, Lee SY, Lee YJ (2020) Effects of CYP2D6 genetic polymorphism on the pharmacokinetics of metoclopramide. Arch Pharm Res 43(11):1207\u20131213. https:\/\/doi.org\/10.1007\/s12272-020-01293-4","journal-title":"Arch Pharm Res"},{"key":"1422_CR3","first-page":"52","volume":"4","author":"BS Briskin","year":"2000","unstructured":"Briskin BS, Dibirov MD, Evseev IuN, Novosel\u2019tsev OS (2000) Treatment of chronic arterial insufficiency of legs with midocalm in elderly. Khirurgiia (mosk) 4:52\u201354","journal-title":"Khirurgiia (mosk)"},{"issue":"8","key":"1422_CR4","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/j.clinthera.2013.07.158","volume":"35","author":"J Byeon","year":"2013","unstructured":"Byeon J, Lee JY, Jeon JS, Lee JE, Kim SH, Choi CI, Lee YJ, Bae JW, Jang CG, Lee SY (2013) Genetic polymorphism of CYP2D6 significantly affects the pharmacokinetics of tolperisone. Clinical Therapeutics 35(8):e58. https:\/\/doi.org\/10.1016\/j.clinthera.2013.07.158","journal-title":"Clinical Therapeutics"},{"issue":"9","key":"1422_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s12272-018-1075-6","volume":"41","author":"JY Byeon","year":"2018","unstructured":"Byeon JY, Kim YH, Lee CM, Kim SH, Chae WK, Jung EH, Choi CI, Jang CG, Lee SY, Bae JW, Lee YJ (2018) CYP2D6 allele frequencies in Korean population, comparison with East Asian, Caucasian and African populations, and the comparison of metabolic activity of CYP2D6 genotypes. Arch Pharm Res 41(9):921\u2013930. https:\/\/doi.org\/10.1007\/s12272-018-1075-6","journal-title":"Arch Pharm Res"},{"issue":"11","key":"1422_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s12272-015-0646-z","volume":"38","author":"JY Byeon","year":"2015","unstructured":"Byeon JY, Kim YH, Na HS, Jang JH, Kim SH, Lee YJ, Bae JW, Kim IS, Jang CG, Chung MW, Lee SY (2015) Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites. Arch Pharm Res 38(11):2083\u20132091. https:\/\/doi.org\/10.1007\/s12272-015-0646-z","journal-title":"Arch Pharm Res"},{"issue":"2","key":"1422_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s12272-018-1099-y","volume":"42","author":"JY Byeon","year":"2019","unstructured":"Byeon JY, Lee CM, Lee YJ, Kim YH, Kim SH, Jung EH, Chae WK, Lee YJ, Jang CG, Lee SY (2019) Influence of CYP2D6 genetic polymorphism on pharmacokinetics of active moiety of tolterodine. Arch Pharm Res 42(2):182\u2013190. https:\/\/doi.org\/10.1007\/s12272-018-1099-y","journal-title":"Arch Pharm Res"},{"issue":"5","key":"1422_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12272-022-01388-0","volume":"45","author":"CK Cho","year":"2022","unstructured":"Cho CK, Kang P, Park HJ, Ko E, Mu CY, Lee YJ, Choi CI, Kim HS, Jang CG, Bae JW, Lee SY (2022) Physiologically based pharmacokinetic (PBPK) modeling of piroxicam with regard to CYP2C9 genetic polymorphism. Arch Pharm Res 45(5):352\u2013366. https:\/\/doi.org\/10.1007\/s12272-022-01388-0","journal-title":"Arch Pharm Res"},{"issue":"11","key":"1422_CR9","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s12272-021-01357-z","volume":"44","author":"CK Cho","year":"2021","unstructured":"Cho CK, Kang P, Park HJ, Lee YJ, Bae JW, Jang CG, Lee SY (2021a) Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele. Arch Pharm Res 44(11):1037\u20131049. https:\/\/doi.org\/10.1007\/s12272-021-01357-z","journal-title":"Arch Pharm Res"},{"issue":"12","key":"1422_CR10","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1007\/s12272-021-01361-3","volume":"44","author":"CK Cho","year":"2021","unstructured":"Cho CK, Park HJ, Kang P, Moon S, Lee YJ, Bae JW, Jang CG, Lee SY (2021b) Physiologically based pharmacokinetic (PBPK) modeling of meloxicam in different CYP2C9 genotypes. Arch Pharm Res 44(12):1076\u20131090. https:\/\/doi.org\/10.1007\/s12272-021-01361-3","journal-title":"Arch Pharm Res"},{"issue":"12","key":"1422_CR11","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1177\/0091270011432168","volume":"52","author":"CI Choi","year":"2012","unstructured":"Choi CI, Bae JW, Jang CG, Lee SY (2012a) Tamsulosin exposure is significantly increased by the CYP2D6*10\/*10 genotype. J Clin Pharmacol 52(12):1934\u20131938. https:\/\/doi.org\/10.1177\/0091270011432168","journal-title":"J Clin Pharmacol"},{"key":"1422_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchromb.2012.10.027","volume":"911","author":"CI Choi","year":"2012","unstructured":"Choi CI, Park JI, Lee HI, Lee YJ, Jang CG, Bae JW, Lee SY (2012b) Determination of tolperisone in human plasma by liquid chromatography\/tandem mass spectrometry for clinical application. J Chromatogr B Analyt Technol Biomed Life Sci 911:59\u201363. https:\/\/doi.org\/10.1016\/j.jchromb.2012.10.027","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1422_CR13","first-page":"57","volume-title":"Basic & clinical pharmacology","author":"MA Correia","year":"2021","unstructured":"Correia MA (2021) Drug biotransformation. In: Katzung BG, Vanderah TW (eds) Basic & clinical pharmacology, 15th edn. McGraw Hill, New York, pp 57\u201376","edition":"15"},{"issue":"5","key":"1422_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/dmd.31.5.631","volume":"31","author":"B Dalmadi","year":"2003","unstructured":"Dalmadi B, Leibinger J, Szeber\u00e9nyi S, Borb\u00e1s T, Farkas S, Szombathelyi Z, Tihanyi K (2003) Identification of metabolic pathways involved in the biotransformation of tolperisone by human microsomal enzymes. Drug Metab Dispos 31(5):631\u2013636. https:\/\/doi.org\/10.1124\/dmd.31.5.631","journal-title":"Drug Metab Dispos"},{"key":"1422_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1254\/jjp.26.543","volume":"26","author":"Y Furuta","year":"1976","unstructured":"Furuta Y, Yoshikawa A (1976) Reversible adrenergic alpha-receptor blocking action of 2,4\u2019-dimethyl-3-piperidino-propiophenone (tolperisone). Jpn J Pharmacol 26:543\u2013550. https:\/\/doi.org\/10.1254\/jjp.26.543","journal-title":"Jpn J Pharmacol"},{"issue":"4","key":"1422_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/00008571-199608000-00008","volume":"6","author":"I Johansson","year":"1996","unstructured":"Johansson I, Lundqvist E, Dahl ML, Ingelman-Sundberg M (1996) PCR-based genotyping for duplicated and deleted CYP2D6 genes. Pharmacogenetics 6(4):351\u2013355. https:\/\/doi.org\/10.1097\/00008571-199608000-00008","journal-title":"Pharmacogenetics"},{"issue":"12","key":"1422_CR17","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s12272-021-01363-1","volume":"44","author":"EH Jung","year":"2021","unstructured":"Jung EH, Cho CK, Kang P, Park HJ, Lee YJ, Bae JW, Choi CI, Jang CG, Lee SY (2021) Physiologically based pharmacokinetic modeling of candesartan related to CYP2C9 genetic polymorphism in adult and pediatric patients. Arch Pharm Res 44(12):1109\u20131119. https:\/\/doi.org\/10.1007\/s12272-021-01363-1","journal-title":"Arch Pharm Res"},{"issue":"9","key":"1422_CR18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s12272-020-01250-1","volume":"43","author":"EH Jung","year":"2020","unstructured":"Jung EH, Lee CM, Byeon JY, Shin HB, Oh KY, Cho CK, Lim CW, Jang CG, Lee SY, Lee YJ (2020a) Relationship between plasma exposure of zolpidem and CYP2D6 genotype in healthy Korean subjects. Arch Pharm Res 43(9):976\u2013981. https:\/\/doi.org\/10.1007\/s12272-020-01250-1","journal-title":"Arch Pharm Res"},{"issue":"12","key":"1422_CR19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1007\/s12272-020-01300-8","volume":"43","author":"EH Jung","year":"2020","unstructured":"Jung EH, Lee YJ, Kim DH, Kang P, Lim CW, Cho CK, Jang CG, Lee SY, Bae JW (2020b) Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes. Arch Pharm Res 43(12):1356\u20131363. https:\/\/doi.org\/10.1007\/s12272-020-01300-8","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1422_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s12272-018-1005-7","volume":"41","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, Byeon JY, Kim YH, Kim SH, Lee CM, Jung EH, Chae WK, Lee YJ, Jang CG, Lee SY, Choi CI (2018a) Effect of the CYP2D6*10 allele on the pharmacokinetics of clomiphene and its active metabolites. Arch Pharm Res 41(3):347\u2013353. https:\/\/doi.org\/10.1007\/s12272-018-1005-7","journal-title":"Arch Pharm Res"},{"issue":"2","key":"1422_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12272-021-01366-y","volume":"45","author":"NT Kim","year":"2022","unstructured":"Kim NT, Cho CK, Kang P, Park HJ, Lee YJ, Bae JW, Jang CG, Lee SY (2022) Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects. Arch Pharm Res 45(2):114\u2013121. https:\/\/doi.org\/10.1007\/s12272-021-01366-y","journal-title":"Arch Pharm Res"},{"issue":"1","key":"1422_CR22","doi-asserted-by":"publisher","first-page":"12405","DOI":"10.1038\/s41598-018-30841-8","volume":"8","author":"SH Kim","year":"2018","unstructured":"Kim SH, Byeon JY, Kim YH, Lee CM, Lee YJ, Jang CG, Lee SY (2018b) Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes. Sci Rep 8(1):12405. https:\/\/doi.org\/10.1038\/s41598-018-30841-8","journal-title":"Sci Rep"},{"issue":"7","key":"1422_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s12272-021-01346-2","volume":"44","author":"YH Kim","year":"2021","unstructured":"Kim YH, Kang P, Cho CK, Jung EH, Park HJ, Lee YJ, Bae JW, Jang CG, Lee SY (2021) Physiologically based pharmacokinetic (PBPK) modeling for prediction of celecoxib pharmacokinetics according to CYP2C9 genetic polymorphism. Arch Pharm Res 44(7):713\u2013724. https:\/\/doi.org\/10.1007\/s12272-021-01346-2","journal-title":"Arch Pharm Res"},{"issue":"3","key":"1422_CR24","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1124\/jpet.105.089805","volume":"315","author":"P Kocsis","year":"2005","unstructured":"Kocsis P, Farkas S, Fodor L, Bielik N, Th\u00e1n M, Kolok S, Gere A, Csejtei M, Tarnawa I (2005) Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels. J Pharmacol Exp Ther 315(3):1237\u20131246. https:\/\/doi.org\/10.1124\/jpet.105.089805","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"1422_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s12272-019-01201-5","volume":"42","author":"Choong-Min Lee","year":"2019","unstructured":"Lee CM, Jung EH, Byeon JY, Kim SH, Jang CG, Lee YJ, Lee SY (2019) Effects of steady-state clarithromycin on the pharmacokinetics of zolpidem in healthy subjects. Arch Pharm Res 42(12):1101\u20131106. https:\/\/doi.org\/10.1007\/s12272-019-01201-5","journal-title":"Archives of Pharmacal Research"},{"issue":"6","key":"1422_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12272-022-01394-2","volume":"45","author":"CM Lee","year":"2022","unstructured":"Lee CM, Kang P, Cho CK, Park HJ, Lee YJ, Bae JW, Choi CI, Kim HS, Jang CG, Lee SY (2022) Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes. Arch Pharm Res 45(6):433\u2013445. https:\/\/doi.org\/10.1007\/s12272-022-01394-2","journal-title":"Arch Pharm Res"},{"issue":"2","key":"1422_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/s0378-1119(98)00567-8","volume":"226","author":"E Lundqvist","year":"1999","unstructured":"Lundqvist E, Johansson I, Ingelman-Sundberg M (1999) Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes. Gene 226(2):327\u2013338. https:\/\/doi.org\/10.1016\/s0378-1119(98)00567-8","journal-title":"Gene"},{"issue":"6","key":"1422_CR27","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1067\/mcp.2001.120675","volume":"70","author":"R Mendoza","year":"2001","unstructured":"Mendoza R, Wan YJ, Poland RE, Smith M, Zheng Y, Berman N, Lin KM (2001) CYP2D6 polymorphism in a Mexican American population. Clin Pharmacol Ther 70(6):552\u2013560. https:\/\/doi.org\/10.1067\/mcp.2001.120675","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"1422_CR28","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0731-7085(87)80082-1","volume":"5","author":"P Miskolczi","year":"1987","unstructured":"Miskolczi P, Vereczkey L, Frenkl R (1987) Gas-liquid chromatographic method for the determination of tolperisone in human plasma: pharmacokinetic and comparative bioavailability studies. J Pharm Biomed Anal 5(7):695\u2013700. https:\/\/doi.org\/10.1016\/0731-7085(87)80082-1","journal-title":"J Pharm Biomed Anal"},{"issue":"6","key":"1422_CR29","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00228-015-1856-5","volume":"71","author":"M Pawlowska","year":"2015","unstructured":"Pawlowska M, Bogiel M, Duda J, Sieradzki E (2015) Influence of CYP2D6 and CYP2C19 genetic polymorphism on the pharmacokinetics of tolperisone in healthy volunteers. Eur J Clin Pharmacol 71(6):699\u2013705. https:\/\/doi.org\/10.1007\/s00228-015-1856-5","journal-title":"Eur J Clin Pharmacol"},{"key":"1422_CR30","first-page":"369","volume":"133","author":"C Ribi","year":"2003","unstructured":"Ribi C, Vermeulen C, Hauser C (2003) Anaphylactic reactions to tolperisone (Mydocalm). Swiss Med Wkly 133:369\u2013371","journal-title":"Swiss Med Wkly"},{"issue":"11","key":"1422_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s12272-020-01294-3","volume":"43","author":"HB Shin","year":"2020","unstructured":"Shin HB, Jung EH, Kang P, Lim CW, Oh KY, Cho CK, Lee YJ, Choi CI, Jang CG, Lee SY, Bae JW (2020) ABCB1 c.2677G>T\/c.3435C>T diplotype increases the early-phase oral absorption of losartan. Arch Pharm Res. 43(11):1187\u20131196. https:\/\/doi.org\/10.1007\/s12272-020-01294-3","journal-title":"Arch Pharm Res."},{"key":"1422_CR32","first-page":"127","volume":"58","author":"A Vora","year":"2010","unstructured":"Vora A (2010) Tolperisone. J Assoc Physicians India 58:127\u2013128","journal-title":"J Assoc Physicians India"},{"issue":"8","key":"1422_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12272-022-01403-4","volume":"45","author":"SS Whang","year":"2022","unstructured":"Whang SS, Cho CK, Jung EH, Kang P, Park HJ, Lee YJ, Choi CI, Bae JW, Kim HS, Jang CG, Lee SY (2022) Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes. Arch Pharm Res 45(8):584\u2013595. https:\/\/doi.org\/10.1007\/s12272-022-01403-4","journal-title":"Arch Pharm Res"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-022-01422-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01422-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T04:52:15Z","timestamp":1675054335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-022-01422-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1422"],"URL":"https:\/\/doi.org\/10.1007\/s12272-022-01422-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"13 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}